[1]
Abou-Sleiman, P.M. et al. 2006. Expanding insights of mitochondrial dysfunction in Parkinson’s disease. Nature Reviews Neuroscience. 7, 3 (Mar. 2006), 207–219. DOI:https://doi.org/10.1038/nrn1868.
[2]
Altshuler, D. et al. 2008. Genetic Mapping in Human Disease. Science. 322, 5903 (Nov. 2008), 881–888. DOI:https://doi.org/10.1126/science.1156409.
[3]
Antonarakis, S.E. and Beckmann, J.S. 2006. Mendelian disorders deserve more attention. Nature Reviews Genetics. 7, 4 (Mar. 2006), 277–282. DOI:https://doi.org/10.1038/nrg1826.
[4]
Atherosclerosis — An Inflammatory Disease — NEJM: .
[5]
Balding, D.J. 2006. A tutorial on statistical methods for population association studies. Nature Reviews Genetics. 7, 10 (Oct. 2006), 781–791. DOI:https://doi.org/10.1038/nrg1916.
[6]
Bishop, M. et al. 2007. Handbook of statistical genetics. John Wiley.
[7]
Botstein, D. and Risch, N. 2003. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nature Genetics. 33, 3s (Mar. 2003), 228–237. DOI:https://doi.org/10.1038/ng1090.
[8]
Bras, J.M. and Singleton, A. 2009. Genetic susceptibility in Parkinson’s disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1792, 7 (Jul. 2009), 597–603. DOI:https://doi.org/10.1016/j.bbadis.2008.11.008.
[9]
Brinkman, R.R. et al. 2006. Human monogenic disorders — a source of novel drug targets. Nature Reviews Genetics. 7, 4 (Mar. 2006), 249–260. DOI:https://doi.org/10.1038/nrg1828.
[10]
Burton, Paul et al. 2011. An introduction to genetic epidemiology. Policy Press.
[11]
Capecchi, M.R. 2005. Essay: Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century. Nature Reviews Genetics. 6, 6 (Jun. 2005), 507–512. DOI:https://doi.org/10.1038/nrg1619.
[12]
Daly, A.K. 2010. Genome-wide association studies in pharmacogenomics. Nature Reviews Genetics. 11, 4 (Apr. 2010), 241–246. DOI:https://doi.org/10.1038/nrg2751.
[13]
Foulkes, Andrea S. 2009. Applied statistical genetics with R: for population-based association studies. Springer.
[14]
Gibb, Alasdair J. et al. 2011. Textbook of receptor pharmacology. CRC Press.
[15]
Hall, I.P. and Pirmohamed, M. 2006. Pharmacogenetics. Taylor & Francis.
[16]
Hansson, G.K. and Libby, P. 2006. The immune response in atherosclerosis: a double-edged sword. Nature Reviews Immunology. 6, 7 (Jun. 2006), 508–519. DOI:https://doi.org/10.1038/nri1882.
[17]
Hirschhorn, J.N. and Daly, M.J. 2005. Genome-wide association studies for common diseases and complex traits. Nature Reviews Genetics. 6, 2 (Feb. 2005), 95–108. DOI:https://doi.org/10.1038/nrg1521.
[18]
Holmes, M.V. 2011. CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular EventsA Systematic Review and Meta-analysis. JAMA: The Journal of the American Medical Association. 306, 24 (Dec. 2011). DOI:https://doi.org/10.1001/jama.2011.1880.
[19]
Holmes, M.V. et al. 2009. Fulfilling the Promise of Personalized Medicine? Systematic Review and Field Synopsis of Pharmacogenetic Studies. PLoS ONE. 4, 12 (Dec. 2009). DOI:https://doi.org/10.1371/journal.pone.0007960.
[20]
Holmes, M.V. et al. 2009. Fulfilling the Promise of Personalized Medicine? Systematic Review and Field Synopsis of Pharmacogenetic Studies. PLoS ONE. 4, 12 (Dec. 2009). DOI:https://doi.org/10.1371/journal.pone.0007960.
[21]
Humphries, S.E. and Hingorani, A. 2006. Pharmacogenetics: Progress, pitfalls and clinical potential for coronary heart disease. Vascular Pharmacology. 44, 2 (Feb. 2006), 119–125. DOI:https://doi.org/10.1016/j.vph.2005.10.003.
[22]
Kathiresan, S. et al. 2009. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nature Genetics. 41, 3 (Feb. 2009), 334–341. DOI:https://doi.org/10.1038/ng.327.
[23]
Kenakin, Terrence P. 2009. A pharmacology primer: theory, applications, and methods. Elsevier Academic Press.
[24]
Kirkwood, Betty R. et al. 2003. Essential medical statistics. Blackwell Science.
[25]
Lee, A.J.X. and Swanton, C. 2012. Tumour heterogeneity and drug resistance: Personalising cancer medicine through functional genomics. Biochemical Pharmacology. 83, 8 (Apr. 2012), 1013–1020. DOI:https://doi.org/10.1016/j.bcp.2011.12.008.
[26]
Lefkowitz, R.J. 2004. Historical review: A brief history and personal retrospective of seven-transmembrane receptors. Trends in Pharmacological Sciences. 25, 8 (Aug. 2004), 413–422. DOI:https://doi.org/10.1016/j.tips.2004.06.006.
[27]
Lesk, Arthur M. 2008. Introduction to bioinformatics. Oxford University Press.
[28]
McCarthy, M.I. et al. 2008. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nature Reviews Genetics. 9, 5 (May 2008), 356–369. DOI:https://doi.org/10.1038/nrg2344.
[29]
Neale, Benjamin M. and International Workshop of Twin and Family Studies 2008. Statistical genetics: gene mapping through linkage and association. Taylor & Francis.
[30]
Neubig, R.R. 2003. International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative Pharmacology. Pharmacological Reviews. 55, 4 (Dec. 2003), 597–606. DOI:https://doi.org/10.1124/pr.55.4.4.
[31]
O’Connor, T.P. and Crystal, R.G. 2006. Genetic medicines: treatment strategies for hereditary disorders. Nature Reviews Genetics. 7, 4 (Apr. 2006), 261–276. DOI:https://doi.org/10.1038/nrg1829.
[32]
Orengo, Christine Ann et al. 2003. Bioinformatics: genes, proteins and computers. BIOS.
[33]
Ropers, H.-H. 2007. New Perspectives for the Elucidation of Genetic Disorders. The American Journal of Human Genetics. 81, 2 (Aug. 2007), 199–207. DOI:https://doi.org/10.1086/520679.
[34]
Seifert, R. and Wenzel-Seifert, K. 2002. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn-Schmiedeberg’s Archives of Pharmacology. 366, 5 (Nov. 2002), 381–416. DOI:https://doi.org/10.1007/s00210-002-0588-0.
[35]
Sham, P. 2007. Statistics in human genetics. Wiley.
[36]
Table of contents : Nature Reviews Genetics Focus on Monogenic disorders: .
[37]
Thomas, Duncan C. 2004. Statistical methods in genetic epidemiology. Oxford University Press.
[38]
Thompson, A.J. et al. 2010. The structural basis of function in Cys-loop receptors. Quarterly Reviews of Biophysics. 43, 04 (Nov. 2010), 449–499. DOI:https://doi.org/10.1017/S0033583510000168.
[39]
Yusuf, S. et al. 2004. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet. 364, 9438 (Sep. 2004), 937–952. DOI:https://doi.org/10.1016/S0140-6736(04)17018-9.
[40]
Zvelebil, Marketa J. and Baum, Jeremy O. 2008. Understanding bioinformatics. Garland Science.
[41]
New Perspectives for the Elucidation of Genetic Disorders. DOI:https://doi.org/520679.